Watch Dr. Afshin Safavi, BioAgilytix Global CSO discuss why it is important to look at ROI when deciding on what new bioanalytical technologies to invest in – both from a financial perspective, and in the effort it will take to move a drug forward as part of the “Business of Bioanalysis” panel hosted by Bioanalysis Zone.
*Video Produced by Bioanalysis Zone
Services
Platforms
